Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Chief Lyle Turner to Step Down Jan. 1; CEO, Chair Posts to Split

NEW YORK, Dec. 5 - Lyle Turner, the gregarious founder, CEO, and chairman of Invitrogen, will step down at the end of the year, the company said today.

 

James Glynn, Invitrogen's executive vice president and former CFO, has been named president and COO. When Turner leaves Jan. 1, Glynn will assume the role of interim CEO until a permanent chief is hired. Bradley Lorimier, a current board member, will become chairman.

 

Invitrogen said it hopes to have a new CEO in place before the end of June, though the company said it has no specific timeline.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.